MedTrace Logo

Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms

NCT04303143 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-07-29

No results posted yet for this study

Summary

Study will look at a limited number of participants with various chronic symptoms. Investigating a new and novel form of hypnosis application called "Direct Autonomic Experience (DAX)" which is using combination of visualization, metaphor, post-hypnotic suggestion and anchoring.

Purpose is to confirm that DAX generally appears to impact SUDS value and subjects report observed level of effect on short and longer term measurements.

Most significantly, testing that DAX technique/action is reusable later if the measured SUDS value returns or increases.

Conditions

Interventions

BEHAVIORAL

Self-Hypnosis

Self-Hypnosis

BEHAVIORAL

Direct Autonomic Experience Control

Direct Autonomic Experience Control. Use of learned mental tool/process to affect outcome measure of SUDS discomfort experience. (eg. Squeeze hand as pre-learned mental anchor to relieve discomfort in lower legs)

Sponsors & Collaborators

  • Inner Group Inc.

    lead INDUSTRY

Principal Investigators

  • Martin Vendemia, BCH, MNLP · Inner Group Inc.

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-05-31
Completion
2021-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04303143 on ClinicalTrials.gov